Venture Certified
| 신기술기업(고도기술수반산업) | 2006-01-13 ~ 2008-01-12 | 61522032100020 | - |
| 연구개발유형 | 2008-01-13 ~ 2010-01-12 | 20080400055 | 2008-02-15 |
| 연구개발유형 | 2010-01-13 ~ 2012-01-12 | 20100400119 | 2008-02-15 |
| 기술평가보증기업(기금) | 2012-06-07 ~ 2014-06-06 | 20120105252 | 2008-02-15 |
| 기술평가보증기업(기금) | 2014-06-07 ~ 2016-06-06 | 20140108045 | 2008-02-15 |
| 기술평가보증기업(기금) | 2016-06-07 ~ 2018-06-06 | 20160108503 | 2008-02-15 |
| 기술평가보증기업(기금) | 2018-06-07 ~ 2020-06-06 | 20180107203 | 2008-02-15 |
| 연구개발유형 | 2020-06-07 ~ 2022-06-06 | 20200106855 | 2008-02-15 |
| 연구개발유형 | 2022-06-07 ~ 2025-06-06 | 20220818020019 | 2008-02-15 |
| 연구개발유형 | 2025-06-07 ~ 2028-06-06 | 20250708020013 | 2008-02-15 |
Revenue CAGR -20.0%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 21B | 20B | 33B |
| Operating Profit | -0.2B | -0.6B | 8.5B |
| Net Profit | -2.1B | -1.6B | 8.8B |
| Total Assets | 63B | 66B | 70B |
| Total Liabilities | 32B | 32B | 33B |
| Total Equity | 32B | 34B | 37B |
Operating Loss: Op. profit -1,85010K
2 Consecutive Years of Net Loss
▼ 20.5%
▼ 104.7%
▼ 107.7%
▲ 8.0%
▼ 170.1%
| Name | Position | Role |
|---|---|---|
| 이시흥 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대전광역시 유성구",
"ceo_name": "이시흥",
"certificate": [
{
"cert_number": "61522032100020",
"changes": "",
"disclosure_date": "2006-01-13",
"first_cert_date": "",
"no": "1",
"type": "신기술기업(고도기술수반산업)",
"valid_period": "2006-01-13 ~ 2008-01-12"
},
{
"cert_number": "20080400055",
"changes": "",
"disclosure_date": "2008-02-15",
"first_cert_date": "2008-02-15",
"no": "2",
"type": "연구개발유형",
"valid_period": "2008-01-13 ~ 2010-01-12"
},
{
"cert_number": "20100400119",
"changes": "",
"disclosure_date": "2010-03-08",
"first_cert_date": "2008-02-15",
"no": "3",
"type": "연구개발유형",
"valid_period": "2010-01-13 ~ 2012-01-12"
},
{
"cert_number": "20120105252",
"changes": "",
"disclosure_date": "2012-06-07",
"first_cert_date": "2008-02-15",
"no": "4",
"type": "기술평가보증기업(기금)",
"valid_period": "2012-06-07 ~ 2014-06-06"
},
{
"cert_number": "20140108045",
"changes": "",
"disclosure_date": "2014-07-04",
"first_cert_date": "2008-02-15",
"no": "5",
"type": "기술평가보증기업(기금)",
"valid_period": "2014-06-07 ~ 2016-06-06"
},
{
"cert_number": "20160108503",
"changes": "",
"disclosure_date": "2016-07-14",
"first_cert_date": "2008-02-15",
"no": "6",
"type": "기술평가보증기업(기금)",
"valid_period": "2016-06-07 ~ 2018-06-06"
},
{
"cert_number": "20180107203",
"changes": "",
"disclosure_date": "2018-06-12",
"first_cert_date": "2008-02-15",
"no": "7",
"type": "기술평가보증기업(기금)",
"valid_period": "2018-06-07 ~ 2020-06-06"
},
{
"cert_number": "20200106855",
"changes": "",
"disclosure_date": "2020-05-26",
"first_cert_date": "2008-02-15",
"no": "8",
"type": "연구개발유형",
"valid_period": "2020-06-07 ~ 2022-06-06"
},
{
"cert_number": "20220818020019",
"changes": "",
"disclosure_date": "2022-08-18",
"first_cert_date": "2008-02-15",
"no": "9",
"type": "연구개발유형",
"valid_period": "2022-06-07 ~ 2025-06-06"
},
{
"cert_number": "20250708020013",
"changes": "",
"disclosure_date": "2025-07-08",
"first_cert_date": "2008-02-15",
"no": "10",
"type": "연구개발유형",
"valid_period": "2025-06-07 ~ 2028-06-06"
}
],
"company_name": "(주)제넷바이오",
"corp_no": "161311-*******",
"financials": {
"2022": {
"capital_stock": 50000000,
"cost_of_sales": 1359055000,
"current_assets": 1472929000,
"current_liabilities": 372687000,
"gross_profit": 1933006000,
"net_income": 883469000,
"net_income_bs": 743148000,
"non_current_assets": 5554823000,
"non_current_liabilities": 2970000000,
"non_operating_expenses": 171033000,
"non_operating_income": 205909000,
"operating_profit": 848593000,
"revenue": 3292061000,
"sga_expenses": 1084413000,
"total_assets": 7027752000,
"total_equity": 3685065000,
"total_liabilities": 3342687000
},
"2023": {
"capital_stock": 50000000,
"cost_of_sales": 813414000,
"current_assets": 1501523000,
"current_liabilities": 188094000,
"gross_profit": 1193691000,
"net_income": -161993000,
"net_income_bs": -161993000,
"non_current_assets": 5082643000,
"non_current_liabilities": 3023000000,
"non_operating_expenses": 136274000,
"non_operating_income": 35735000,
"operating_profit": -61454000,
"revenue": 2007105000,
"sga_expenses": 1255145000,
"total_assets": 6584166000,
"total_equity": 3373072000,
"total_liabilities": 3211094000
},
"2024": {
"capital_stock": 50000000,
"cost_of_sales": 950531000,
"current_assets": 1621875000,
"current_liabilities": 151365000,
"gross_profit": 1156231000,
"net_income": -212295000,
"net_income_bs": -212295000,
"non_current_assets": 4713267000,
"non_current_liabilities": 3023000000,
"non_operating_expenses": 226270000,
"non_operating_income": 32470000,
"operating_profit": -18495000,
"revenue": 2106762000,
"sga_expenses": 1174726000,
"total_assets": 6335142000,
"total_equity": 3160777000,
"total_liabilities": 3174365000
}
},
"industry": "그 외 기타 분류 안된 화학제품 제조업",
"investment": [],
"main_products": "생명공학용 시약, 진단시약",
"phone": "042-361-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |